London, UK, 28 September 2018 - Instinctif Partners, the business communications consultancy, congratulates all of the shortlisted companies of the Scrip Awards 2018. Now in its 14th year, the Scrip Awards acknowledge the highest achievers across the pharmaceutical and biotech industries, recognising both corporate and individual achievement.
Congratulations goes especially to Instinctif Partners Life Sciences’ clients F-star, Roche, Crescendo, Abcam and IQVIA who have been shortlisted across the 17 award categories. These are:
Abcam
Crescendo Biologics
F-star
IQVIA
Roche
The Scrip Awards recognise success across a range of industry activities, including novel deals, new drug launches and technological breakthroughs in clinical trials.
The winners of the Scrip Awards will be announced at a prestigious dinner and ceremony taking place on 28 November at the Hilton on Park Lane, London. The full list of award categories and winners, as selected by a panel of 17 highly respected judges, can be found here.
Commenting on the announcement of the finalists, Sue Charles, Managing Partner of Instinctif Partners Life Sciences’ practice said:
“The eagerly anticipated Scrip Awards reflect significant achievements throughout our sector and the quality of nominations are always very high. This year’s shortlist reflects a strong year of innovation across the board and it is great to see the accomplishments of our clients recognised at such a distinguished industry event.”
About Instinctif Partners Life Sciences
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.